These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11062767)

  • 41. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
    Solomon MJ; McLeod RS
    CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for colorectal cancer on the front line.
    Lemon SC; Zapka JG; Estabrook B; Erban S; Luckmann R
    Am J Gastroenterol; 2003 Apr; 98(4):915-23. PubMed ID: 12738477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colorectal cancer: a summary of the evidence for screening and prevention.
    Wilkins T; Reynolds PL
    Am Fam Physician; 2008 Dec; 78(12):1385-92. PubMed ID: 19119558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for colorectal cancer.
    Waldby G; Ryan JJ
    S D Med; 2010 May; 63(5):175-7. PubMed ID: 20462062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
    Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The detection of colorectal cancer at an asymptomatic stage by screening is useful.
    Komuta K; Furui J; Haraguchi M; Kanematsu T
    Hepatogastroenterology; 2000; 47(34):1011-4. PubMed ID: 11020866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colonoscopy screening among US adults aged 40 or older with a family history of colorectal cancer.
    Tsai MH; Xirasagar S; Li YJ; de Groen PC
    Prev Chronic Dis; 2015 May; 12():E80. PubMed ID: 25996988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests.
    Cheng TI; Wong JM; Hong CF; Cheng SH; Cheng TJ; Shieh MJ; Lin YM; Tso CY; Huang AT
    J Formos Med Assoc; 2002 Oct; 101(10):685-90. PubMed ID: 12517041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colorectal cancer screening in Massachusetts: measuring compliance with current guidelines.
    Erban S; Zapka J; Puleo E; Vickers-Lahti M
    Eff Clin Pract; 2001; 4(1):10-7. PubMed ID: 11234181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement.
    Ko CW; Kreuter W; Baldwin LM
    BMC Gastroenterol; 2005 Mar; 5():10. PubMed ID: 15755323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surveillance behavior of women with a reported family history of colorectal cancer.
    Clavel-Chapelon F; Joseph R; Goulard H
    Prev Med; 1999 Feb; 28(2):174-8. PubMed ID: 10048109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of family history of colorectal cancer in primary care: perceptions of first degree relatives of people with colorectal cancer.
    Cameron E; Rose S; Carey M
    Patient Educ Couns; 2014 Mar; 94(3):427-31. PubMed ID: 24380670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams.
    Zheng YF; Saito T; Takahashi M; Ishibashi T; Kai I
    BMC Public Health; 2006 Nov; 6():272. PubMed ID: 17083746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of the efficacy of screening tests in colorectal cancer by faecal occult blood test--own experience.
    Kozłowski T; Godlewski D; Biczysko M; Grochowalski M; Nelke M; Paszkowski J; Borejsza-Wysocki M; Krokowicz L; Krokowicz P; Banasiewicz T; Drews M
    Pol Przegl Chir; 2011 Aug; 83(8):411-23. PubMed ID: 22166714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening preferences for colorectal cancer: a patient demographic study.
    Sheikh RA; Kapre S; Calof OM; Ward C; Raina A
    South Med J; 2004 Mar; 97(3):224-30. PubMed ID: 15043327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.
    Samadder NJ; Curtin K; Tuohy TM; Rowe KG; Mineau GP; Smith KR; Pimentel R; Wong J; Boucher K; Burt RW
    Gastroenterology; 2014 Oct; 147(4):814-821.e5; quiz e15-6. PubMed ID: 25042087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of colorectal cancer screening in diverse primary care practices.
    Zimmerman RK; Nowalk MP; Tabbarah M; Grufferman S
    BMC Health Serv Res; 2006 Sep; 6():116. PubMed ID: 16970813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
    Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
    Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Feasibility of sigmoidoscopic screening for colorectal cancer in the Hunter Region.
    Agrez MV; Redman S; Sanson-Fisher R; Hennrikus D
    Aust N Z J Surg; 1990 Feb; 60(2):87-92. PubMed ID: 2327918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.